BioSpace News Archive

Amgen Inc. announced the early tender results of its previously announced nine separate private offers to exchange certain specified series of its outstanding senior notes for a combination of a cash payment and new Senior Notes due 2053.

Aug. 13, 2020 13:00 UTC CAMBRIDGE, Mass.--( BUSINESS WIRE )-- E25Bio, rapid diagnostic innovators, announces award funding of $4.14M from the Bill & Melinda Gates Foundation and $1.68M from the NIH’s Small Business Innovation Research (SBIR) program. The pair of funding awards comes months after the startup announces funding from Khosla Ventures to develop and commercialize a rapid, inexpensive diagnostic for the COVID-19 pandemic. Launched in 2000, the Gates Foundation f

Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (OTCQB:SMTI), a provider of wound and skincare products dedicated to improving patient outcomes, announced today its strategic, operational and financial results for the quarter and six-months ended June 30, 2020.

SWORD Health, a leading provider of digital musculoskeletal (MSK) care, today announced SWORD Health’s digital therapy platform and several of its applications have earned Certified status for information security by HITRUST.

PAO Group, Inc. (USOTC: PAOG) today announced Goldman Small Cap Research has published an initial analyst report covering PAOG’s outlook following two recent acquisitions moving the company into the cannabis biopharma market sector

Transaction adds late-stage orphan pipeline asset and platform in inflammation and fibrosis. Calliditas to acquire 62.7% of Genkyotex for €20.3M in cash at €2.80 per share in an off-market transaction.

Isofol Medical AB, has announced that it entered into a license agreement with Solasia Pharma K.K, to develop and commercialize Isofol’s proprietary late-stage drug candidate arfolitixorin in Japan.

The anticipated development growth of the global life science tools market is likely to be supported by rapid adoption of technological inventions by the various companies operating the market.

The global urinalysis market is marked by fierce competition among the leading players. Most companies are keen on developing new technology to improve efficiency of test results and reduce time.

The global urolithiasis management devices market has a highly competitive vendor landscape, observes Transparency Market Research.